Market Overview

UPDATE: Deutsche Bank Upgrades Acadia Healthcare to Buy; Compelling Growth Momentum

Share:
Related ACHC
5 Mid-Cap Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years
Earnings Scheduled For February 11, 2015
Looking for a Growth Stock? Why It is Time to Focus on Acadia Healthcare Company (ACHC) - Tale of the Tape (Zacks)

Deutsche Bank raises its rating on Acadia Healthcare (NASDAQ: ACHC) from Hold to Buy and increases its price target from $15 to $19.

Deutsche Bank comments, "Our stance upon initiation of coverage (Jan 2012) was simple: growth will be good but the shares may pull back and offer a better entry point. With the recent equity offering, the balance sheet and capacity to accretively acquire put it in a place where the next meaningful N-T move in the shares is likely to be up and not down, in our view. Given the growth outlook and improved capital structure, we believe a higher multiple is warranted (we go from 8.5x to 9.5x 2013E EV/EBITDA or 20x P/E) bringing our PT to $19 from $15."

ACHC closed at $16.51 on Wednesday.

Latest Ratings for ACHC

DateFirmActionFromTo
Apr 2015JefferiesMaintainsBuy
Apr 2015Wells FargoUpgradesMarket PerformOutperform
Apr 2015Cantor FitzgeraldMaintainsBuy

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Upgrades Price Target Intraday Update Analyst Ratings

 

Related Articles (ACHC)

Around the Web, We're Loving...